Composite membranes modified with recognition-able nanobeads as potential adsorbers for purification of biological fluids

Journal of Applied Biomaterials and Biomechanics

Volumn 5, Issue 3, 2007, Pages 166-175

  Silvestri, Davide ^a   Cristallini, C ^b   Borrelli, C ^a,d   Barbani, N ^a   Giusti, P ^a,b   Ciardelli, G ^a,c  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c POLITECNICO DI TORINO   (Italy)

^d TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Cholesterol; Molecular imprinting; Nanobeads; Selective membranes

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHACRYLIC ACID METHYL ESTER; NANOBEAD; POLYACRYLIC ACID; POLYMETHACRYLIC ACID;

ADSORPTION; ARTICLE; BINDING SITE; BODY FLUID; COMPOSITE MATERIAL; INFRARED SPECTROMETRY; MEMBRANE; MOLECULAR IMPRINTING; PHASE SEPARATION; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; PURIFICATION; SCANNING ELECTRON MICROSCOPY;

EID: 41849137565     PISSN: 17226899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary prevention Study (WOSCOPS). Circulation 1998; 97: 1440-5.
2. Scandinavian Simvastatin Survival Study (4S) Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344: 1383-9.
3. Stegmayr BG. A survey of blood purification techniques. Transfus Apher Sci 2005; 32: 209-20.
4. Bosch T. Recent advances in therapeutic apheresis. J Artif Organs 2003; 6: 1-8.
5. Bosch T. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis. Transfuss Apher Sci 2004; 31: 83-8.
6. Wendler T, Lennertz A, Heinemann O, Duhr C, Samtleben W, Bosch T. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility. Int J Artif Organs 2000; 23: 710-7.
7. Otto C, Kern P, Bambauer R, Kallert S, Schwandt P, Parhofer KG. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (liposorber D) in severe hypercholesterolemia. Artif Organs 2003; 27: 1116-22.
8. Jovin IS, Taborski U, Muller-Berghaus G. Analysis of the long-term efficacy and selectivity of immunoadsorption columns for low density lipoprotein apheresis. ASAIO J 2000; 46: 298-300.
9. Mosbach K, Ramstrom O. The emerging technique of molecular imprinting and its future impact on biotechnology. Nat Biotechnol 1996; 14: 163-70.
10. Wulff G. Molecular imprinting in cross-linked materials with the aid of molecular templates: a way towards artificial antibodies. Angew Chem Int Ed 1995; 34: 1812-32.
11. Shea KJ. Molecular imprinting of synthetic network polymers: the de novo synthesis of macromolecular binding and catalytic sites. Trends Polym Sci 1994; 2: 166-73.
12. Vlatakis G, Andersson O, Muller R, Mosbach K. Drug assay using antibody mimics made by molecular imprinting. Nature 1993; 361: 645-7.
13. Mosbach K. Molecular imprinting. Trends Biochem 1994; 19: 9-14.
14. Wang HI, Kobayashi T, Fujii N. Molecular imprint membranes prepared by the phase inversion precipitation technique. Langmuir 1996; 12: 4850-6.
15. Sellergren B, Shea KJ. Chiral ion-exchange chromatography: Correlation between solute retention and theoretical ion-exchange model using imprinted polymers. J Chromatogr A 1993; 654: 17-28.
16. Whitcombe MJ, Rodriguez ME, Villar P, Vulfson EN. A new method for the introduction of recognition site functionality into polymers prepared by molecular imprinting: synthesis and characterization of polymeric receptors for cholesterol. J Am Chem Soc 1995; 117: 7105-11.
17. Sellergren B, Wieschemeyer J, Boos KS, Seid D. Imprinted polymers for selective adsorption of cholesterol from gastrointestinal fluids. Chem Mater 1998; 10: 4037-46.
18. Hwang CC, Lee WC. Chromatographic characteristics of cholesterol- imprinted polymers prepared by covalent and non-covalent imprinting methods. J Chromatogr A 2002; 962: 69-78.
19. Asanuma H, Kakazu M, Shibata M, Hishiya T, Komiyama M. Synthesis of molecularly imprinted polymers of β-cyclodextrin for the efficient recognition of cholesterol. Supramolecular Science 1998; 5: 417-21.
20. Zhong N, Byun HS, Bittman R. Hydrophilic cholesterol-binding molecular imprinted polymers. Tetrahedron Lett 2001; 42: 1839-41.
21. Asanuma H, Hishiya T, Komiyama M. Tailor-made receptors by molecular imprinting. Adv Mater 2000, 12: 1019-30.
22. Hishiya T, Shibata M, Kakazu M, Asanuma H, Komiyama M. Molecularly imprinted cyclodextrins as selective receptors for steroids. Macromolecules 1999; 32: 2265-9.
23. Sreenivasan K. Synthesis and evaluation of a beta cyclodextrin-based molecularly imprinted copolymer. J Appl Polym Sci 1998; 70: 15-8.
24. Pérez N, Whitcombe MJ, Vulfson EN. Surface imprinting of cholesterol on submicrometer core-shell emulsion particles. Macromolecules 2001; 34: 830-6.
25. Pérez N, Whitcombe MJ, Vulfson EN. Molecularly imprinted nanoparticles prepared by core-shell emulsion polymerization. J Appl Polym Sci 2000; 77: 1851-9.
26. Kugimiya A, Kuwada Y, Takeuchi T. Preparation of sterol-imprinted polymers with the use of 2-(methacryloyloxy) ethyl phosphate. J Chromatogr A 2001; 938: 131-5.
27. Davidson L, Blencowe A, Drew MGB, Freebairn KW, Hayes W. Synthesis and evaluation of a solid supported molecular tweezer type receptor for cholesterol. J Mater Chem 2003; 13: 758-66.
28. Gore MA, Karmalkar RN, Kulkarni MG. Enhanced capacities and selectivities for cholesterol in aqueous media by molecular imprinting: role of novel cross-linkers. J Chromatogr B 2004; 804: 211-21.
29. Cristallini C, Ciardelli G, Barbani N, Giusti P. Acrylonitrile-acrylic acid copolymer membrane imprinted with uric acid for clinical uses. Macromol Biosci 2004; 4: 31-8.
30. Ciardelli G, Cioni B, Cristallini C, Barbani N, Silvestri D, Giusti P. Acrylic polymeric nanospheres for the release and recognition of molecules of clinical interest. Biosens Bioelectron 2004; 20: 1083-90.
31. Silvestri D, Borrelli C, Giusti P, Cristallini C, Ciardelli G. Polymeric devices containing imprinted nanospheres: a novel approach to improve recognition in water for clinical uses. Analytica Chimica Acta 2005; 542: 3.